Zoledronic acid early increases serum osteoprotegerin in early stage multiple myeloma.

被引：0
|
作者：
Gozzetti, Alessandro [1 ]
Martini, Giuseppe [1 ]
Salvadori, Stefania [1 ]
Gennari, Luigi [1 ]
Avanzati, Annalisa [1 ]
Franci, Beatrice [1 ]
Carnpagna, Maria Stella [1 ]
Nuti, Ranuccio [1 ]
Lauria, Francesco [1 ]
机构：
[1] Univ Siena, I-53100 Siena, Italy
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3588.3588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3588
引用
收藏
页码：1025A / 1025A
页数：1
相关论文
共 50 条
  • [31] Abnormal MRI of spine is the dominant risk factor for early progression of asymptomatic multiple myeloma.
    Wang, M
    Alexanian, R
    Delasalle, K
    Weber, D
    BLOOD, 2003, 102 (11) : 687A - 688A
  • [32] Zoledronic acid acutely increases serum sclerostin levels
    Reactions Weekly, 2013, 1450 (1) : 3 - 3
  • [33] Zoledronic acid prevents bone loss in early-stage breast cancer
    Francesco Bertoldo
    Giuseppe Tonini
    Bruno Vincenzi
    Daniele Santini
    Nature Reviews Clinical Oncology, 2009, 6 : 191 - 192
  • [34] Zoledronic acid prevents bone loss in early-stage breast cancer
    Bertoldo, Francesco
    Tonini, Giuseppe
    Vincenzi, Bruno
    Santini, Daniele
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (04) : 191 - 192
  • [35] Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
    Michael Gnant
    Current Oncology Reports, 2012, 14 : 35 - 43
  • [36] The effects of zoledronic acid dose and infusion rate on pharmacokinetics (PK), pharmacodynamics (PD), and renal function in patients with multiple myeloma.
    Berenson, JR
    Major, P
    Swift, RA
    Vescio, R
    Rivera, C
    Bilic, S
    Gauron, S
    Denouel, J
    Schran, H
    BLOOD, 2005, 106 (11) : 382B - 382B
  • [37] Zoledronic acid may reduce early-stage breast cancer relapse
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1019 - 1019
  • [38] Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
    Gnant, Michael
    CURRENT ONCOLOGY REPORTS, 2012, 14 (01) : 35 - 43
  • [39] Zoledronic acid decreases serum low-density lipoprotein cholesteol in multiple myeloma patients
    Martini, G.
    Gozzetti, A.
    Gennari, L.
    Salvadori, S.
    Merlotti, D.
    Avanzati, A.
    Franci, B.
    Camiagna, M.
    Lauria, F.
    Nuti, R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S410 - S410
  • [40] All-trans retinoic acid for multiple myeloma.
    Weber, DM
    Bseiso, A
    Wood, A
    Gavino, M
    Alexanian, R
    BLOOD, 1997, 90 (10) : 1593 - 1593
12345